Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
Conditions
Antiphospholipid Syndrome (APS) · Bullous Pemphigoid (BP) · Behçet's Syndrome (BS) · Dermatomyositis (DM) · Immune-mediated Necrotizing Myopathy (IMNM) · Immune Thrombocytopenia (ITP)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of California-Irvine, Orange, California, United States
Johns Hopkins University, Baltimore, Maryland, United States
Northwell Health, LLC PRIME, Lake Success, New York, United States
Hospital for Special Surgery, New York, New York, United States
Universtity of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
Ohio State University, Columbus, Ohio, United States
Oregon Health & Science University, Portland, Oregon, United States
University of Pennsylvania, Perelman Center for Advanced Medicine, Philadelphia, Pennsylvania, United States
Amarillo Center for Clinical Research, Amarillo, Texas, United States
Austin Neuromuscular Center, Austin, Texas, United States
Nerve and Muscle Center of Texas, Houston, Texas, United States
Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia
Westmead Hospital, Sydney, New South Wales, Australia
Campbelltown Public Hospital, Sydney, New South Wales, Australia
The Alfred Hospital, Melbourne, Victoria, Australia
Box Hill Hospital, Melbourne, Victoria, Australia
AKH - Medizinische Universitaet Wien, Abteilung fuer Klinische Pharmakologie, Vienna, Austria
Diagnostic Consultation Center CONVEX EOOD, Sofia, Sofia City Province, Bulgaria
"SHATHD" EAD Sofia, Sofia, Sofia City Province, Bulgaria
UMHAT "Prof. Dr. St. Kirkovich", AD, Stara Zagora, Stara Zagora Province, Bulgaria
University of Alberta Hospital - Department of Anesthesiology and Pain Medicine, Edmonton, Alberta, Canada
University of Alberta Hospital - Dermatology, Edmonton, Alberta, Canada
The Royal Institution for the Advancement of Learning/McGill University, Montreal, Quebec, Canada
Centre de Rhumatologie de l'Est du Quebec, Rimouski, Quebec, Canada
DIEX Recherche Sherbrooke Inc., Sherbrooke, Quebec, Canada
Clinical Hospital Center "Sestre Milosrdnice", Zagreb, City of Zagreb, Croatia
University hospital centre Zagreb, Zagreb, City of Zagreb, Croatia
Specialty Hospital Medico, Rijeka, Primorje-Gorski Kotar County, Croatia
Sanatorium Profesora Arenbergera, Prague, Prague, Czechia
Hopital Lapeyronie,Service d'Immuno Rhumatologie, Montpellier, Occitanie, France
AP-HP Hôpital Universitaire Pitié Salpêtrière, Paris, Île-de-France Region, France
Universitaetsklinikum Tuebingen, Tübingen, Baden-Wurttemberg, Germany
Universitaetsklinikum Erlangen, Erlangen, Bavaria, Germany
Universitaetsklinikum Carl Gustav Carus TU Dresden, Klinik und Poliklinik f. Dermatologie, Sachsen, Bundesländer, Germany
Universitaetsmedizin Goettingen, Göttingen, Göttingen District, Germany
Universitaetsklinikum Schleswig Holstein - Campus Luebeck, Klinik f Dermatologie, Allergologie u Venerologie, Lübeck, Schleswig-Holstein, Germany
Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikai Kozpont, Szeged, Csongrád-Csanád County, Hungary
Semmelweis Egyetem, Budapest, Hungary
IRCCS Istituto Scientifico Romagnolo Per Lo Studio Dei Tumori "Dino Amadori" - IRST, Meldola, Forlì-Cesena Province, Italy
Istituto Clinico Humanitas, Milan, Milan Province, Italy
Ospedale San Giovanni Bosco, Torino, Turin Province, Italy
Hokkaido University Hospital, Sapporo, Hokkaido, Japan
Tohoku University Hospital, Sendai, Miyagi, Japan
Kindai University Hospital, Sayama, Osaka, Japan
Osaka University Hospital, Suita, Osaka, Japan
Hamamatsu University Hospital, Hamamatsu, Shizuoka, Japan
National Center of Neurology and Psychiatry, Kodaira, Tokyo, Japan
Toho University Omori Medical Center, Ōta-ku, Tokyo, Japan
Okayama University Hospital, Okayama, Japan
University Medical Centre Groningen UMCG, Groningen, Groningen Province, Netherlands
UMC Utrecht, Utrecht, Utrecht Province, Netherlands
Sorlandet sykehus Kristiansand, Kristiansand, Agder County, Norway
Stavanger Universitetssjukehus, Stavanger, Rogaland County, Norway
Institute Reumatologii I'm. Eleonory Reicher, Warsaw, Masovian Voivodeship, Poland
Centro Clinico Academico Braga, Braga, Braga District, Portugal
Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E., Vila Nova de Gaia, Porto District, Portugal
Centrul Medical Monza SRL, Bucharest, Bucharest Municipality, Romania
Oncology Institute Prof. Dr. Ion Chiricuta I.O.C.N., Cluj-Napoca, Cluj, Romania
Clinica Universidad de Navarra, Pamplona, Community of Madrid & Navarre, Spain
Hospital Universitario Ramon y Cajal, Servicio de Reumatologia, Madrid, Madrid, Spain
Hospital Universitario 12 de October, Madrid, Madrid, Spain
Hospital Universitari Vall d'Hebron, Internal Medicine Dept., Barcelona, Province of Barcelona and Catalonia, Spain
Hospital Universitario Reina Sofia, Córdoba, Province Of Córdoba, Spain
Hospital Universitario Virgen del Rocio, Seville, Province Of Seville, Spain
Hospital Universitari i Politecnic La Fe, Valencia, Valencia, Spain
National Taiwan University Hospital, Taipei, Taiwan
Taichung Veterans General Hospital, Taipei, Taiwan
Dr. Abdurrahman Yurtaslan Oncology Teaching and Research Hospital, Ankara, Ankara, Turkey (Türkiye)
Istanbul University Istanbul Medical Faculty, Istanbul, Istanbul, Turkey (Türkiye)
Study leads
Sponsor Chugai Pharmaceutical Co.Ltd
Study Director
clinical-trials@chugai-pharm.co.jp